Eko, the company that makes smart electronic stethoscopes that we’re very fond of and which is sponsoring our popular Medgadget 2018 Sci-Fi Writing Contest, has now partnered with the Mayo Clinic to develop automated tools to screen patients for heart conditions. Initially, they’re focusing the attention on spotting low ejection fraction, an indication of a weak […]
Month: October 2018
Masimo’s High Accuracy RD SET Pulse Oximeters Cleared by FDA
Masimo won FDA clearance for its RD SET sensors that feature the company’s “Measure-through Motion” and “Low Perfusion SET” pulse oximetry. The new disposable oximeters are supposedly twice as accurate than Masimo’s previous offerings for patients over 3 kg, having an accuracy spec of 1.5% at 1 standard deviation, compared to 3% before. The devices […]
HoloLens Used to Looks at Heart Scars in High Resolution
At the Beth Israel Deaconess Medical Center in Boston, researchers have been investigating the use of the Microsoft HoloLens augmented reality headset for visualizing myocardial scars during surgical interventions. During ablations and other electrophysiology procedures, the surgeon must have a good idea of where scars and other relevant items are within the heart. Typically, this […]
Studies show that non-invasive imaging can detect Alzheimer’s disease
Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzhe…
Common diabetes medication may protect against age-related macular degeneration
Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration.
United States Uveitis Market and Competitive Landscape Report 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Uveitis Market and Competitive Landscape – 2018” report has been added to ResearchAndMarkets.com’s offering. The latest research US Uveitis Market and Competitive Landscape – 2018, provides comprehensive insights into U…
OpRegen shows positive phase 1/2a study results for dry AMD
CHICAGO — OpRegen, a retinal pigment epithelium cell therapy transplant for dry age-related macular degeneration, has shown signs of improving the retina structurally and decreasing drusen density, according to press release from BioTime.Early data fro…
Electronic Synthetic Cells Small Enough for Injections
If injectable autonomous robots are to be used in medicine, they must be tiny and capable of being manufactured by the million. They must also have some kind of electronics inside for diagnostic or therapeutic capabilities. Researches at MIT have developed a method for producing so-called “syncells,” or synthetic cells, that can process data inputs […]
Microchip for Growing and Studying 3D Brain Mimics
Over the past few years, neuroscientists have been able to grow ever larger and more complex spheroid cultures and organoids that replicate the structure and functionality of brain tissue. While these models are significantly better at mimicking parts of the brain compared to 2D cultures, they are much more challenging to study because it’s hard […]
More refractive lens exchange cases per week lead to lower rate of complications
CHICAGO — More surgeries per week lead to a lower rate of surgical complications during refractive lens exchange, according to a speaker here.According to the results of a retrospective case study, surgical volume and age have an associated impact on t…
Integration of new technology may improve ophthalmologic care
CHICAGO — Artificial intelligence, deep learning systems and automated diagnostic systems can improve ophthalmologic care for patients and provide help for overburdened ophthalmologists.At a press conference, Vinay A. Shah, MD, and Robert Chang, MD, pr…
Intravitreal corticosteroids superior in treatment of uveitic macular edema
CHICAGO — Intravitreal triamcinolone and intravitreal dexamethasone sustained-release implant were both superior to periocular triamcinolone for the regional treatment of uveitic macular edema, according to a speaker here.The multicenter, randomized PO…
New and Expanded Health Coverage Highlight Care N’ Care’s 2019 Benefits
FORT WORTH, Texas–(BUSINESS WIRE)–#carencare–Care N’ Care’s 2019 benefits plans include greater choice, new and enhanced benefits, and expansion into additional counties throughout North Texas.
BioTime Presents New OpRegen® Data at American Academy of Ophthalmology Annual Meeting
ALAMEDA, Calif.–(BUSINESS WIRE)–$BTX–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced positive additional results from an ongoing Phase I/IIa study of its lead prod…
Global Age-Related Macular Degeneration Market and Competitive Landscape Report 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Age-Related Macular Degeneration Market and Competitive Landscape – 2018” report has been added to ResearchAndMarkets.com’s offering. Global Age-Related Macular Degeneration Market and Competitive Landscape – 2018, …
Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting
Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer’s Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanu…
Ophthalmology on the road to value-based care
CHICAGO – Transitioning from a volume-based system to a value-based one is the future of medicine in this country, and ophthalmology is a specialty best-suited to lead that charge, according to a speaker here.“The road to the future for our profession …
Cornea donor characteristics less important than recipient’s
CHICAGO – The Eye Bank Association of America’s minimum standards for cornea tissue yields reliable results with donor characteristics mattering less than recipient characteristics, according to a speaker here.Studies have shown donor age is not associ…
Regenxbio presents phase 1 data for wet AMD gene therapy
CHICAGO — The 6-month results of an ongoing phase 1 study evaluating RGX-314 gene therapy for patients with wet AMD showed positive safety and patient tolerability outcomes, according to a speaker here.The therapy is designed to deliver a gene encoding…
The system works: Withdrawal of CyPass from the market
CHICAGO — The voluntary withdrawal of CyPass from the global market shocked the field of ophthalmology, but the process in place worked nicely to approve the device and, in turn, take it off the market, according to a speaker here.In August, Alcon issu…